Core Scientific (CORZ) Notes Payables (2021 - 2026)

Core Scientific (CORZ) has 6 years of Notes Payables data on file, last reported at $844.8 million in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables rose 5110.02% year-over-year to $844.8 million; the trailing twelve-month figure through Mar 2026 stood at $844.8 million (up 5110.02% YoY), and the FY2024 full-year result was $16.3 million, down 86.9% from the prior year.
• Notes Payables grew to $844.8 million in Q1 2026, from $16.2 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $977.6 million in Q3 2022 to a low of $5.8 million in Q2 2022.
• A 5-year average of $164.3 million and a median of $27.8 million in 2022 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables surged 6190.32% in 2022 and plunged 86.9% in 2024, its largest moves.
• Tracing CORZ's Notes Payables over 5 years: stood at $36.2 million in 2022, then surged by 243.13% to $124.4 million in 2023, then sank by 86.9% to $16.3 million in 2024, then retreated by 0.47% to $16.2 million in 2025, then soared by 5110.02% to $844.8 million in 2026.
• Business Quant data shows CORZ's Notes Payables at $844.8 million in Q1 2026, $16.2 million in Q1 2025, and $16.3 million in Q4 2024.